Dorotea Rigamonti

4.9k total citations · 2 hit papers
25 papers, 3.7k citations indexed

About

Dorotea Rigamonti is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Dorotea Rigamonti has authored 25 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 4 papers in Developmental Neuroscience. Recurrent topics in Dorotea Rigamonti's work include Genetic Neurodegenerative Diseases (15 papers), Mitochondrial Function and Pathology (10 papers) and Muscle Physiology and Disorders (5 papers). Dorotea Rigamonti is often cited by papers focused on Genetic Neurodegenerative Diseases (15 papers), Mitochondrial Function and Pathology (10 papers) and Muscle Physiology and Disorders (5 papers). Dorotea Rigamonti collaborates with scholars based in Italy, United States and Canada. Dorotea Rigamonti's co-authors include Elena Cattaneo, Chiara Zuccato, Donato Goffredo, Luciano Conti, Michael R. Hayden, Simonetta Sipione, Tõnis Timmusk, Blair R. Leavitt, Marzia Tartari and Marta Valenza and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Dorotea Rigamonti

24 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

2001 1.0k citations Chiara Zuccato, Dorotea Rigamonti et al. profile →
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

2003 720 citations Chiara Zuccato, Marzia Tartari et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dorotea Rigamonti Italy	19	2.6k	2.4k	792	336	305	25	3.7k
Ignacio Muñoz-Sanjuán United States	29	2.4k 0.9×	1.2k 0.5×	470 0.6×	302 0.9×	275 0.9×	82	3.3k
H. Brent Clark United States	26	3.4k 1.3×	3.1k 1.3×	898 1.1×	95 0.3×	306 1.0×	40	4.1k
Abigail S. Hackam United States	34	3.1k 1.2×	2.3k 0.9×	626 0.8×	124 0.4×	225 0.7×	76	4.2k
Donato Goffredo Italy	12	2.0k 0.7×	1.8k 0.8×	543 0.7×	320 1.0×	212 0.7×	14	2.6k
Patrice D. Smith Canada	20	1.8k 0.7×	2.1k 0.9×	960 1.2×	821 2.4×	200 0.7×	33	3.9k
G. Jackson Snipes United States	34	1.6k 0.6×	3.4k 1.4×	1.0k 1.3×	318 0.9×	211 0.7×	47	4.7k
Eva Hedlund Sweden	32	2.6k 1.0×	1.1k 0.4×	716 0.9×	565 1.7×	249 0.8×	58	3.8k
Alanna E. McCall United States	15	3.1k 1.2×	2.6k 1.1×	753 1.0×	183 0.5×	511 1.7×	21	3.6k
Jérôme Mertens United States	24	2.9k 1.1×	1.0k 0.4×	589 0.7×	550 1.6×	298 1.0×	39	4.0k
E. Edward Baetge United States	27	1.4k 0.5×	1.5k 0.6×	344 0.4×	612 1.8×	387 1.3×	46	2.8k

Countries citing papers authored by Dorotea Rigamonti

Since Specialization

Citations

This map shows the geographic impact of Dorotea Rigamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorotea Rigamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorotea Rigamonti more than expected).

Fields of papers citing papers by Dorotea Rigamonti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorotea Rigamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorotea Rigamonti. The network helps show where Dorotea Rigamonti may publish in the future.

Co-authorship network of co-authors of Dorotea Rigamonti

This figure shows the co-authorship network connecting the top 25 collaborators of Dorotea Rigamonti. A scholar is included among the top collaborators of Dorotea Rigamonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorotea Rigamonti. Dorotea Rigamonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riondato, Mattia, Dorotea Rigamonti, Petra Martini, et al.. (2023). Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000–2022). Journal of Medicinal Chemistry. 66(7). 4532–4547. 17 indexed citations

Camnasio, Stefano, et al.. (2010). Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates. BMC Neuroscience. 11(1). 7–7. 10 indexed citations

Rigamonti, Dorotea, et al.. (2009). Turning REST/NRSF Dysfunction in Huntingtons Disease into a Pharmaceutical Target. Current Pharmaceutical Design. 15(34). 3958–3967. 25 indexed citations

Papait, Roberto, Lorenzo Magrassi, Dorotea Rigamonti, & Elena Cattaneo. (2008). Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. Biochemical and Biophysical Research Communications. 379(2). 434–439. 24 indexed citations

Kazantsev, Aleksey, Mattia Sturlese, Stefano Moro, et al.. (2008). SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington’s disease. Bioorganic & Medicinal Chemistry. 16(10). 5695–5703. 41 indexed citations

Rigamonti, Dorotea, Daniele Bolognini, Chiara Zuccato, et al.. (2007). Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators. Journal of Biological Chemistry. 282(34). 24554–24562. 38 indexed citations

Wang, Xin, Malini Narayanan, Jean‐Marie Bruey, et al.. (2006). Protective role of Cop in Rip2/Caspase-1/Caspase-4-mediated HeLa cell death. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(8). 742–754. 13 indexed citations

Goffredo, Donato, Dorotea Rigamonti, Chiara Zuccato, et al.. (2005). Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease. Pharmacological Research. 52(2). 140–150. 35 indexed citations

Valenza, Marta, Dorotea Rigamonti, Donato Goffredo, et al.. (2005). Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease. Journal of Neuroscience. 25(43). 9932–9939. 218 indexed citations

10.

Zuccato, Chiara, Daniel Liber, Alessia Tarditi, et al.. (2005). Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacological Research. 52(2). 133–139. 158 indexed citations

11.

Cozzolino, Mauro, Elisabetta Ferraro, Alberto Ferri, et al.. (2004). Apoptosome inactivation rescues proneural and neural cells from neurodegeneration. Cell Death and Differentiation. 11(11). 1179–1191. 40 indexed citations

12.

Cattaneo, Elena, Dorotea Rigamonti, & Chiara Zuccato. (2003). El enigma de la enfermedad de Huntington. 1(8). 32–37.

13.

Zuccato, Chiara, Marzia Tartari, Andrea Crotti, et al.. (2003). Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nature Genetics. 35(1). 76–83. 720 indexed citations breakdown →

14.

Cattaneo, Elena, Dorotea Rigamonti, & Chiara Zuccato. (2002). The Enigma of Huntington's Disease. Scientific American. 287(6). 92–97. 12 indexed citations

15.

Goffredo, Donato, Dorotea Rigamonti, Marzia Tartari, et al.. (2002). Calcium-dependent Cleavage of Endogenous Wild-type Huntingtin in Primary Cortical Neurons. Journal of Biological Chemistry. 277(42). 39594–39598. 71 indexed citations

16.

Rigamonti, Dorotea, Simonetta Sipione, Donato Goffredo, et al.. (2001). Huntingtin's Neuroprotective Activity Occurs via Inhibition of Procaspase-9 Processing. Journal of Biological Chemistry. 276(18). 14545–14548. 123 indexed citations

17.

Conti, Luciano, Simonetta Sipione, Lorenzo Magrassi, et al.. (2001). Shc signaling in differentiating neural progenitor cells. Nature Neuroscience. 4(6). 579–586. 94 indexed citations

18.

Ehrlich, Michelle E., Luciano Conti, Mauro Toselli, et al.. (2001). ST14A Cells Have Properties of a Medium-Size Spiny Neuron. Experimental Neurology. 167(2). 215–226. 62 indexed citations

19.

Varani, Katia, Dorotea Rigamonti, Simonetta Sipione, et al.. (2001). Aberrant amplification of A _2A receptor signaling in striatal cells expressing mutant huntingtin. The FASEB Journal. 15(7). 1245–1247. 65 indexed citations

20.

Benedetti, Sara, Bianca Pollo, Lorenzo Magrassi, et al.. (2000). Gene therapy of experimental brain tumors using neural progenitor cells. Nature Medicine. 6(4). 447–450. 367 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact